key: cord-0710682-s4feedff
authors: Corley, Michael J.; Pang, Alina P.S.; Dody, Kush; Mudd, Philip A.; Patterson, Bruce K.; Seethamraju, Harish; Bram, Yaron; Peluso, Michael J.; Torres, Leonel; Iyer, Nikita S.; Premeaux, Thomas A.; Yeung, Stephen T.; Chandar, Vasuretha; Borczuk, Alain; Schwartz, Robert E.; Henrich, Timothy J.; Deeks, Steven G.; Sacha, Jonah B.; Ndhlovu, Lishomwa C.
title: Genome‐wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID‐19
date: 2021-01-19
journal: J Leukoc Biol
DOI: 10.1002/jlb.5hi0720-466r
sha: 8a0419874f29db02ee3349b5412797164016261f
doc_id: 710682
cord_uid: s4feedff

The global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a highly pathogenic RNA virus causing coronavirus disease 2019 (COVID‐19) in humans. Although most patients with COVID‐19 have mild illness and may be asymptomatic, some will develop severe pneumonia, acute respiratory distress syndrome, multi‐organ failure, and death. RNA viruses such as SARS‐CoV‐2 are capable of hijacking the epigenetic landscape of host immune cells to evade antiviral defense. Yet, there remain considerable gaps in our understanding of immune cell epigenetic changes associated with severe SARS‐CoV‐2 infection pathology. Here, we examined genome‐wide DNA methylation (DNAm) profiles of peripheral blood mononuclear cells from 9 terminally‐ill, critical COVID‐19 patients with confirmed SARS‐CoV‐2 plasma viremia compared with uninfected, hospitalized influenza, untreated primary HIV infection, and mild/moderate COVID‐19 HIV coinfected individuals. Cell‐type deconvolution analyses confirmed lymphopenia in severe COVID‐19 and revealed a high percentage of estimated neutrophils suggesting perturbations to DNAm associated with granulopoiesis. We observed a distinct DNAm signature of severe COVID‐19 characterized by hypermethylation of IFN‐related genes and hypomethylation of inflammatory genes, reinforcing observations in infection models and single‐cell transcriptional studies of severe COVID‐19. Epigenetic clock analyses revealed severe COVID‐19 was associated with an increased DNAm age and elevated mortality risk according to GrimAge, further validating the epigenetic clock as a predictor of disease and mortality risk. Our epigenetic results reveal a discovery DNAm signature of severe COVID‐19 in blood potentially useful for corroborating clinical assessments, informing pathogenic mechanisms, and revealing new therapeutic targets against SARS‐CoV‐2.

RNA viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are capable of inducing immune dysfunction through hijacking host immune cell epigenomes and altering transcriptional programs to evade immune defenses. 1 Epigenetics offers a window into understanding host-pathogen interactions decoding the biologic dialogue between host and pathogen and understanding pathogenrelated disease outcomes. [2] [3] [4] [5] Increasing evidence has shown that various components of the host immune system are dramatically altered during SARS-CoV-2 infection and the extent of immune dysregulation relates to severe COVID-19 disease and mortality. 6 Based on accumulating evidence reporting dramatic change in the composition of immune cell types in severe COVID-19, 12,16-18 our initial analysis of our DNAm dataset investigated differences in estimated cell-type proportions between groups utilizing cell-type-specific differential methylation profiles. 16 We utilized the Epigenetic Dissection of Intra-Sample-Heterogeneity (EpiDISH) package 19, 20 to infer fractions of 7 priori immune cell subtypes (B-cells, CD4+ T Cells, CD8+

T cells, NK cells, monocytes, neutrophils, and eosinophils) based on 3 methods: Robust Partial Correlations, 16 CIBERSORT, 21 and Constrained projection 22 Genome-wide DNAm data have been used to develop epigenetic clocks to accurately estimate chronologic age and a predictor of lifespan in immune cells and tissues. [28] [29] [30] [31] Infectious diseases such as HIV accelerate the epigenetic clock 32,33 suggestive of damaging effects of an RNA pathogen on the host immune cell epigenome. To study epigenetic age in severe COVID-19, we examined Horvath's measure of epigenetic age acceleration according to the PhenoAge epigenetic clock 29 and assessed DNAm inferred mortality risk according to GrimAge. 30 Individuals with severe COVID-19 were estimated to have a significantly increased epigenetic age acceleration compared with uninfected controls and influenza (P < 0.05; Fig. 2A ). Moreover, we also observed a significant increase in mortality risk in severe COVID-19 compared with uninfected controls, primary HIV, and HIV/COVID-19 coinfection (P < 0.05; Fig. 2B ). Interestingly, we did not observe significant decreases in DNAm-based telomere length in severe COVID-19 compared with uninfected controls (P value = 0.22; Fig. 2C ). However, validating previous reports in HIV, we found that individuals coinfected with HIV and mild/moderate COVID-19 had an estimated significantly shorter telomere length compared with uninfected controls, influenza, and severe COVID-19 (P < 0.05; Fig. 2C ). We also utilized our DNAm dataset to infer previously validated DNAm-based biomarker estimates for mortality including renal function biomarker cystatin C and fibrosis marker TIMP metallopeptidase inhibitor 1 (TIMP-1). 30 Estimated levels of biomarkers cystatin and TIMP-were significantly increased in severe COVID-19 compared with uninfected controls (P < 0.05) and influenza (P < 0.05) ( Fig. 2D 

Suppression of the antiviral response by an influenza histone mimic

Comparative DNA methylation profiling reveals an immunoepigenetic signature of HIV-related cognitive impairment

Comparative DNA methylomic analyses reveal potential origins of novel epigenetic biomarkers of insulin resistance in monocytes from virally suppressed HIV-infected adults

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals

Zika virus alters DNA methylation status of genes involved in Hippo signaling pathway in human neural progenitor cells

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Epigenetic landscape during coronavirus infection

MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape

Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses

Imbalanced host response to SARS-CoV-2 drives development of COVID-19

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling

High frequency of SARS-CoV-2 RNAemia and association with severe disease

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

A comparison of reference-based algorithms for correcting cell-type heterogeneity in epigenome-wide association studies

EpiDISH web server: epigenetic dissection of intra-sample-heterogeneity with online GUI

Robust enumeration of cell subsets from tissue expression profiles

DNA methylation arrays as surrogate measures of cell mixture distribution

Emergence of low-density inflammatory neutrophils correlates with hypercoagulable state and disease severity in COVID-19 patients

Targeting potential drivers of COVID-19: neutrophil extracellular traps

SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues

eFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data

Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes

Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies

An epigenetic biomarker of aging for lifespan and healthspan

DNA methylation GrimAge strongly predicts lifespan and healthspan

DNA methylation age of human tissues and cell types

HIV-1 infection accelerates age according to the epigenetic clock

An epigenetic clock measures accelerated aging in treated HIV infection

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells

SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling

SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2

Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19